ifosfamide has been researched along with Malignant Melanoma in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A phase II study with cisplatin plus 24-hour infusion of ifosfamide (with mesna uroprotection) was performed in patients with metastatic malignant melanoma." | 7.68 | Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma. ( Planting, AS; Stoter, G; van der Gaast, A; Verweij, J, 1990) |
| "Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 7.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
| "Ifosfamide was tested in a phase II study in 12 evaluable patients with advanced malignant melanoma." | 7.67 | Phase II study with ifosfamide in advanced malignant melanoma. ( Bajetta, E; Bonfante, V; Ferrari, L; Negretti, E, 1988) |
| "Twenty-five patients with measurable lesions of advanced malignant melanoma received a combined chemotherapy containing cis-dichlordiammineplatinum (II) (cisplatin) 30 mg daily at days 1, 3, 5, 7, 9, and ifosfamide 45 mg/kg at days 2, 4, 6, 8, and 10." | 7.66 | Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma. ( Becher, R; Schmidt, CG; Seeber, S, 1980) |
| " Both have a dose-response relationship." | 6.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
| "Vaginal melanoma is a very rare but highly malignant gynecological disease, usually diagnosed in postmenopausal woman." | 6.43 | Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. ( Garbi, A; Lissoni, AA; Mangioni, C; Perego, P; Signorelli, M, 2005) |
| "Thirty-seven patients with widely metastatic malignant melanoma were treated with one of three chemotherapy regimens, incorporating high-dose dacarbazine (DTIC)." | 3.67 | High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. ( Carr, T; Chadwick, G; Craig, P; Jones, R; Lind, M; Morgenstern, G; Thatcher, D, 1989) |
| "Ifosfamide was tested in a phase II study in 12 evaluable patients with advanced malignant melanoma." | 3.67 | Phase II study with ifosfamide in advanced malignant melanoma. ( Bajetta, E; Bonfante, V; Ferrari, L; Negretti, E, 1988) |
| "Twenty-five patients with measurable lesions of advanced malignant melanoma received a combined chemotherapy containing cis-dichlordiammineplatinum (II) (cisplatin) 30 mg daily at days 1, 3, 5, 7, 9, and ifosfamide 45 mg/kg at days 2, 4, 6, 8, and 10." | 3.66 | Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma. ( Becher, R; Schmidt, CG; Seeber, S, 1980) |
| " Both have a dose-response relationship." | 2.68 | Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. ( de Wit, R; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J, 1996) |
| "Vaginal melanoma is a very rare but highly malignant gynecological disease, usually diagnosed in postmenopausal woman." | 2.43 | Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. ( Garbi, A; Lissoni, AA; Mangioni, C; Perego, P; Signorelli, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Signorelli, M | 1 |
| Lissoni, AA | 1 |
| Garbi, A | 1 |
| Perego, P | 1 |
| Mangioni, C | 1 |
| Focan, C | 1 |
| Salamon, E | 1 |
| Le Hung, S | 1 |
| Frère, MH | 1 |
| Mbuyamba, P | 1 |
| Claessens, JJ | 1 |
| Osieka, R | 1 |
| Costanzi, JJ | 1 |
| Stephens, R | 1 |
| O'Bryan, R | 1 |
| Franks, J | 1 |
| Becher, R | 2 |
| Seeber, S | 1 |
| Schmidt, CG | 2 |
| Balda, BR | 1 |
| Jehn, U | 1 |
| Klövekorn, W | 1 |
| Wohlrab, A | 1 |
| Berdel, WE | 1 |
| Fink, U | 1 |
| Emmerich, B | 1 |
| Maubach, PA | 1 |
| Busch, U | 1 |
| Remy, W | 1 |
| Rastetter, J | 1 |
| Planting, AS | 2 |
| de Wit, R | 1 |
| van der Burg, ME | 1 |
| Stoter, G | 2 |
| Verweij, J | 2 |
| Latz, D | 1 |
| Schulze, T | 1 |
| Manegold, C | 1 |
| Schraube, P | 1 |
| Flentje, M | 1 |
| Weber, KJ | 1 |
| van der Gaast, A | 1 |
| Thatcher, D | 1 |
| Lind, M | 1 |
| Morgenstern, G | 1 |
| Carr, T | 1 |
| Chadwick, G | 1 |
| Jones, R | 1 |
| Craig, P | 1 |
| Tsukagoshi, S | 1 |
| Negretti, E | 1 |
| Ferrari, L | 1 |
| Bonfante, V | 1 |
| Bajetta, E | 1 |
1 review available for ifosfamide and Malignant Melanoma
| Article | Year |
|---|---|
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Melan | 2005 |
1 trial available for ifosfamide and Malignant Melanoma
| Article | Year |
|---|---|
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1996 |
12 other studies available for ifosfamide and Malignant Melanoma
| Article | Year |
|---|---|
[Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results].
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamou | 1984 |
Studies on drug resistance in a human melanoma xenograft system.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease Models, Ani | 1984 |
Ifosfamide in the management of malignant melanoma: a Southwest Oncology Group Phase II Study.
Topics: Bone Marrow; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Humans; Ifosfamide; Me | 1982 |
Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.
Topics: Adult; Aged; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Fe | 1980 |
[Combination chemotherapy with cis-dichloro-diammineplatinum (II) and ifosfamide in malignant melanomas (author's transl)].
Topics: Adult; Cisplatin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mel | 1981 |
[Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
Topics: Adult; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Male; Melanoma; Middle Aged; Skin Neoplasms | 1982 |
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality T | 1998 |
[Combined chemotherapy of metastasing melanoblastoma using ifosfamide and cis-platinum (II)-diamminodichloride (author's transl)].
Topics: Adult; Aged; Cisplatin; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Melanoma; Middle Aged; N | 1979 |
Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Hum | 1990 |
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Ma | 1989 |
[Ifomide].
Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental; | 1987 |
Phase II study with ifosfamide in advanced malignant melanoma.
Topics: Adult; Drug Evaluation; Humans; Ifosfamide; Melanoma; Middle Aged; Neoplasm Metastasis | 1988 |